UC Davis clinical trial shows promising early results for treating COVID-19

Two-thirds of patients improved after taking remdesivir, according to the preliminary findings of recent clinical trials for the drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.